ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc (BMRN)

56.77
0.30
(0.53%)
終了 6月6日 5:00AM
56.77
0.00
( 0.00% )
プレマーケット: 6:04PM

BioMarin Pharmaceutical Inc (BMRN) インサイダー取引

-
フィルター:
日付 保有者名 取引株数 金額レンジ ($) 取引種別 価格レンジ ($) 届出終了時の株数 % 変化
2026-05-20Ms. Cristin HubbardExec. VP & Chief Commercial Officer-2.32k116.36kSale to Issuer50.207.38k-23.89%
2026-05-07Dr. Gregory FribergExec. VP and Chief Research & Development Officer-3.28k176.68k売り53.8551.82k-5.95%
2026-03-18Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary-1.27k71.35kSale to Issuer56.0578.56k-1.59%
2026-03-17Dr. C. Greg GuyerExec. VP & CTO-1.69k94.89kSale to Issuer56.0574.16k-2.23%
2026-03-17Mr. Brian R. MuellerCFO & Exec. VP of Finance-2.12k118.66kSale to Issuer56.05123.31k-1.69%
2026-03-17Mr. Alexander HardyPresident, CEO & Director-4.25k238.32kSale to Issuer56.05214.64k-1.94%
2026-03-17Ms. Cristin HubbardExec. VP & Chief Commercial Officer-1.25k69.78kSale to Issuer56.057.58k-14.11%
2026-03-17Dr. Gregory FribergExec. VP and Chief Research & Development Officer-1.63k91.31kSale to Issuer56.0555.10k-2.87%
2026-03-13Dr. C. Greg GuyerExec. VP & CTO-9.11k532.97kSale to Issuer58.5150.07k-15.39%
2026-03-16Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary-7.18k419.93kSale to Issuer58.5179.83k-8.25%
2026-03-13Mr. Brian R. MuellerCFO & Exec. VP of Finance-9.95k581.88kSale to Issuer58.51125.43k-7.35%
2026-03-16Mr. Alexander HardyPresident, CEO & Director-2.94k172.08kSale to Issuer58.5177.49k-3.66%
2026-03-11Dr. C. Greg GuyerExec. VP & CTO-16.49k996.74k売り60.4644.58k-27.00%
2026-02-26Dr. Gregory FribergExec. VP and Chief Research & Development Officer-6.33k381.94k売り60.3837.58k-14.41%
2026-02-26Mr. George Eric DavisExec. VP, Chief Legal Officer & Secretary-26.06k1.60M売り61.3672.45k-26.45%
2025-12-30Mr. Richard A. Meierインサイダー-500.000.00Other Disposition-120.28k-0.41%
2025-12-01Mr. Alexander HardyPresident, CEO & Director-16.57k911.85kSale to Issuer55.0340.65k-28.96%
2025-09-30Dr. Gregory FribergExec. VP and Chief Research & Development Officer-3.30k178.94kSale to Issuer54.1643.51k-7.06%